These results, along with a past report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,two support the notion of targeting ACKR3 as a novel approach to modulate the opioid technique, which could open up new therapeutic avenues for opioid-associated Conditions. As well as the described https://hatshepsutu456gwu0.wikifrontier.com/user